| Ragia G, Petridis I, Tavridou A, et al. Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. [Journal Article] Pharmacogenomics 2009 Nov; 10(11):1781-7. Abstract | Full Citation |
| Sullivan SD, Alfonso-Cristancho R, Conner C, et al. A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus. [Journal Article] Pharmacotherapy 2009 Nov; 29(11):1280-8. Abstract | Full Citation |
| Strojek K, Bebakar WM, Khutsoane DT, et al. Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. [JOURNAL ARTICLE] Curr Med Res Opin 2009 Oct 12. Abstract | Full Citation | Find Related Articles |
| Ma P, Gu B, Ma J, et al. Glimepiride induces proliferation and differentiation of rat osteoblasts via the PI3-kinase/Akt pathway. [JOURNAL ARTICLE] Metabolism 2009 Oct 1. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Xu H, Murray M, McLachlan AJ Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugs. [Journal Article] Curr Drug Metab 2009 Jul; 10(6):643-58. Abstract | Full Citation | Find Related Articles |
| Khalangot M, Tronko M, Kravchenko V, et al. Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study. [JOURNAL ARTICLE] Diabetes Res Clin Pract 2009 Sep 29. Abstract | Full Citation | Find Related Articles |
| Sharma AK, Srinivasan BP Triple verses Glimepiride plus Metformin therapy on Cardiovascular Risk Biomarkers and Diabetic-Cardiomyopathy in Insulin Resistance Type 2 Diabetes Mellitus Rats. [JOURNAL ARTICLE] Eur J Pharm Sci 2009 Sep 15. Abstract | Full Citation |
| Kazda C, Gallwitz B, Simó R, et al. The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics. [JOURNAL ARTICLE] Diabetes Obes Metab 2009 Sep 13. Abstract | Full Citation | Find Related Articles |
| Croom KF, McCormack PL Liraglutide: a review of its use in type 2 diabetes mellitus. [Journal Article] Drugs 2009; 69(14):1985-2004. Abstract | Full Citation | Find Related Articles |
| John Betteridge D CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone. [JOURNAL ARTICLE] Fundam Clin Pharmacol 2009 Sep 10. Abstract | Full Citation |
 |